What was recalled
The U.S. Food and Drug Administration (FDA) has issued a Class II recall for a specific batch of Fluphenazine HCl Elixir, USP, manufactured by Safecor Health, LLC. This is not a vague or broad safety alert; it targets a very precise pharmaceutical product used to treat certain mental health conditions. The medication in question is an oral elixir containing 2.5 milligrams of fluphenazine hydrochloride per 5 milliliters. It is important to note that this formulation contains 14% alcohol by volume and is intended strictly for oral use. Because it carries the "Rx Only" designation, this medication is available solely by prescription from a licensed healthcare provider.
The recall encompasses multiple lots of this specific elixir, all packaged and distributed by Safecor Health, located in Woburn, Massachusetts. The National Drug Code (NDC) for these products is 00121-0654-16. However, the scope of this recall is defined by specific lot numbers rather than just the brand name. If you have this medication, you must check your bottle against the following lot numbers to determine if it is affected: Lot #26160463 (Expiration Date: 04/20/2027), Lot #25430188 (Expiration Date: 11/26/2026), Lot #25440715 (Expiration Date: 12/9/2026), Lot #25501160 (Expiration Date: 01/21/2027), Lot #26021054 (Expiration Date: 02/5/2027), Lot #26130635 (Expiration Date: 04/3/2027), and Lot #26200964 (Expiration Date: 05/13/2027). The presence of any of these lot numbers on your bottle indicates that the product is part of this recall.
This recall action was initiated on August 13, 2026. It affects products that were distributed nationwide across the United States. While the manufacturer is based in Massachusetts, the reach of this recall extends to pharmacies and healthcare providers in all states who may have received these specific lots. The classification of this recall as a Class II action suggests that use of the product could cause temporary or medically reversible health problems, though it is unlikely to cause serious adverse health consequences. The decision to recall was driven by the manufacturer's testing, which revealed that these lots failed to meet stability specifications. This means that while the drug may look and taste normal, its chemical composition may have degraded in a way that could affect its potency or safety profile, even though it is still within its printed expiration date.
It is crucial to understand that this recall is limited to the specific lots identified above. Other lots of Fluphenazine HCl Elixir produced by Safecor Health or other manufacturers are not included in this alert unless explicitly stated otherwise. If you are unsure whether your medication is part of this recall, do not rely on the expiration date alone. You must locate the lot number printed on the packaging and compare it directly to the list provided by the FDA. This precision ensures that only potentially compromised medications are removed from use, while allowing patients with stable batches to continue their treatment without interruption.
The hazard, explained
This recall centers on a specific type of failure known as "failed stability specifications." To understand what this means for your health, it is helpful to look at the chemistry behind the medication. Fluphenazine HCl Elixir is a prescription drug used to treat mental and mood disorders, such as schizophrenia or acute agitation. Like all medications, its active ingredient—the part that actually treats your condition—is designed to remain chemically stable within a specific range until the expiration date printed on the bottle. Stability specifications are strict guidelines set by the FDA and the manufacturer to ensure that the drug contains exactly the amount of medicine listed on the label and that it has not broken down into potentially harmful byproducts.
When a product fails these stability specifications, it means that laboratory testing has shown the Fluphenazine HCl Elixir does not meet its own quality standards. This failure can manifest in two primary ways, both of which pose significant risks to patients. First, the potency of the drug may have degraded below the labeled strength. If the active ingredient breaks down over time due to improper storage conditions or manufacturing variances, you might be receiving a dose that is significantly weaker than what your doctor prescribed. For a medication like Fluphenazine, which requires precise dosing to maintain mental stability and prevent symptom recurrence, an under-dosed pill or liquid can be dangerous. It may lead to a return of severe symptoms, increased agitation, or other complications that require emergency medical attention.
Second, and perhaps more concerning, is the possibility that the chemical breakdown has created unknown impurities. When the molecular structure of Fluphenazine HCl destabilizes, it can split into different compounds. While not all breakdown products are toxic, some can be harmful to the liver, kidneys, or cardiovascular system. Because this failure was identified after distribution, there is no way for a patient to know visually whether their specific bottle has degraded. The liquid may look clear and normal, but the chemical integrity is compromised. This is why the FDA classifies this as a Class II recall: while it is unlikely to cause serious adverse health effects or death in most cases, it presents a moderate risk that requires immediate correction to prevent treatment failure or exposure to unknown chemical substances.
It is also important to note the context of this specific product. The recalled Fluphenazine HCl Elixir contains 14% alcohol by volume. While this is standard for many liquid formulations to help preserve the drug, the interaction between a potentially degraded active ingredient and the solvent (alcohol) can sometimes accelerate instability if the product has been exposed to temperature fluctuations during storage or transport. The failure indicates that Safecor Health’s quality control processes did not catch these deviations before the bottles left their facility in Woburn, Massachusetts. For patients relying on this medication for chronic management of serious psychiatric conditions, consistency is key. A batch that fails stability tests breaks that chain of reliability, leaving patients vulnerable to unpredictable therapeutic outcomes.
In summary, the hazard here is not an immediate toxic explosion or contamination with foreign objects, but a silent chemical uncertainty. You cannot tell if your medicine is weak or chemically altered by looking at it. The only way to ensure you are receiving a safe and effective dose is to verify that your specific lot numbers are not part of this recall batch. Ignoring the stability failure means risking your treatment plan's effectiveness, which can have serious consequences for your mental health management.
Who is most at risk
To understand who is truly vulnerable in this recall, we first need to look at what Fluphenazine HCl actually is and how it functions in the body. This medication is a high-potency antipsychotic drug belonging to the phenothiazine class. It is prescribed to manage symptoms of severe mental health conditions, such as schizophrenia or other psychotic disorders, by helping to balance certain natural chemicals in the brain. Because it is a powerful prescription-only (Rx) medication, it is not something that is casually taken or easily accessible to the general public. The individuals most directly involved in this recall are patients who have been specifically diagnosed with these conditions and have been prescribed Fluphenazine HCl Elixir by a healthcare provider. However, the risk here is not just about whether you take the drug, but whether that specific bottle of liquid meets safety standards.
The primary hazard in this recall is that the product has failed stability specifications. In plain terms, this means that the chemical composition of the elixir may have degraded or changed in ways that were not anticipated during testing. For a patient relying on a precise dose to maintain mental stability and prevent severe psychiatric symptoms, this instability is particularly concerning. If the active ingredient breaks down too quickly or unevenly, the medication may become less effective than labeled. This creates a silent risk for individuals who are managing serious mental health conditions; they may believe they are receiving their full therapeutic dose when, in reality, the potency could be compromised. This gap between perceived and actual dosing can lead to a return of distressing symptoms that were previously under control.
While the recall does not explicitly single out demographic groups like children or the elderly as uniquely more vulnerable than adults, the nature of this drug implies specific risk factors for certain populations. Fluphenazine is typically prescribed to adults and older adolescents who can communicate their symptoms effectively. However, patients who are elderly or those with compromised liver or kidney function may be at higher risk if the drug’s degradation products accumulate in the body differently than the active ingredient. Furthermore, because this is an oral elixir containing 14% alcohol by volume, individuals who must avoid alcohol due to other medical conditions, pregnancy, or personal recovery journeys face a secondary concern. While the primary issue here is chemical stability, the presence of alcohol in a medication meant for mental health management requires careful consideration by patients with sensitive health profiles.
It is also important to recognize that the risk extends beyond just the patient taking the pill. Family members, caregivers, and pharmacists play a critical role in safety. Caregivers who administer this liquid medication to dependent adults or adolescents must ensure they are using the correct measuring device and are aware of the lot numbers involved. If the stability of the drug is compromised, it could lead to unexpected side effects or a lack of therapeutic benefit, which might be mistaken for a worsening of the underlying mental health condition rather than a manufacturing defect. Therefore, anyone involved in the administration or oversight of this specific Safecor Health product should be considered part of the at-risk circle until they can verify their inventory against the recalled lot numbers.
Ultimately, the people most at risk are those who currently possess any of the six specific lots listed in the official FDA notice: Lot #26160463, Lot #25430188, Lot #25440715, Lot #25501160, Lot #26021054, and Lot #26130635. If you or someone you care for is using Fluphenazine HCl Elixir, USP, 2.5 mg per 5 mL distributed by Safecor Health in Woburn, MA, the potential risk lies in the uncertainty of the medication’s potency and chemical integrity. While the recall is classified as a Class II event—meaning it is likely to cause temporary health problems or serious but not life-threatening adverse reactions—it still demands immediate attention from patients who depend on this medication for their daily stability and well-being.
How to tell if you have the recalled item
Identifying whether your medication is part of this specific recall requires a careful examination of your prescription bottle or packaging. Because this action involves Fluphenazine HCl Elixir, USP, manufactured and distributed by Safecor Health, LLC, you need to look for several precise details printed on the label. The goal is to match the product description, National Drug Code (NDC), lot numbers, and expiration dates exactly. If any of these details do not align with the information below, your medication is likely safe from this particular recall.
First, confirm that you have the correct medication name. The recalled product is explicitly labeled as Fluphenazine HCl Elixir, USP. It is important to note that this specific recall applies only to the formulation that delivers 2.5 mg per 5 mL. The label should also indicate that it is an oral elixir with a PAI (Prescription Only Item) designation and contains 14% alcohol by volume. If your bottle says "Tablet," "Injection," or a different strength, it is not included in this recall.
Next, locate the National Drug Code (NDC). This unique identifier is crucial for verifying the product. For this recall, the affected NDC is 00121-0654-16. You can typically find this code printed on the front or back of the prescription label. If your bottle has a different NDC, it was not part of this specific distribution batch and does not need to be returned.
The most critical step is checking the Lot Number and Expiration Date. Safecor Health recalls six specific lots of this medication. You must look for one of the following lot numbers printed on your label:
- Lot# 26160463 with an expiration date of 04/20/2027
- Lot# 25430188 with an expiration date of 11/26/2026
- Lot# 25440715 with an expiration date of 12/09/2026
- Lot# 25501160 with an expiration date of 01/21/2027
- Lot# 26021054 with an expiration date of 02/05/2027
- Lot# 26130635 with an expiration date of 04/03/2027
- Lot# 26200964 with an expiration date of 05/13/2027
If your bottle lists a lot number that does not match any of these seven codes, or if the expiration date is different from those listed above for the corresponding lot, your medication is not part of this recall. Additionally, while the manufacturer is Safecor Health in Woburn, MA, the primary identifiers are the NDC and Lot Number. Please check your label carefully against these exact details. If you have one of these specific lots, do not stop taking your medication abruptly without consulting your healthcare provider, but contact them or a pharmacist immediately for further instructions on how to proceed.
What to do — step by step
If you or a loved one are currently taking Fluphenazine HCl Elixir, USP, manufactured by Safecor Health, the first and most critical step is to pause and assess your situation with care. This recall has been classified as a Class II action by the FDA, which generally indicates that use of the product may cause temporary health problems or pose a slight threat of a serious nature. The specific reason for this recall is that the medication has failed stability specifications, meaning the chemical integrity of the drug may have degraded over time. While the official recall announcement does not explicitly state a specific remedy such as a mandatory return address or a direct refund process, the standard and safest course of action in pharmaceutical recalls of this nature is to immediately stop using the product. Do not wait for further instructions from your pharmacy to discontinue the medication; instead, treat the potential loss of potency or chemical stability as a significant risk to your health.
Once you have decided to stop using the elixir, your next step is to contact the healthcare provider who prescribed this medication. Fluphenazine HCl is a potent antipsychotic drug often used to manage conditions like schizophrenia. Suddenly stopping psychiatric medication can sometimes lead to withdrawal symptoms or a return of underlying health issues. Therefore, it is vital that you speak with your doctor or psychiatrist before making any permanent changes to your treatment plan. They need to know that the specific batches you possess are part of this nationwide recall so they can evaluate whether you need an alternative prescription immediately. Your provider may switch you to a different manufacturer’s version of Fluphenazine HCl Elixir, which is currently unaffected by this stability issue, or they may adjust your dosage temporarily until a safe supply is secured.
After consulting with your doctor, reach out to the pharmacy where you purchased or filled the prescription. Inform them that you have received notice of the Safecor Health recall involving NDC 00121-0654-16. Ask them how they handle returns for recalled pharmaceuticals. Typically, pharmacies will accept the unused portion of the medication for proper disposal to prevent it from entering the waste stream or being taken by someone else who might not know about the recall. They may also guide you on the administrative steps required to have your insurance cover the cost of a replacement prescription from a different manufacturer. If you have the bottle in your possession, keep it in a safe place out of reach of children and pets until you can return it or dispose of it according to local guidelines.
If you are unsure whether you have one of the affected lots, check your medication bottle carefully against the list provided by the FDA. The recall affects specific lots with expiration dates ranging from late 2026 to early 2027. The affected lot numbers are 26160463, 25430188, 25440715, 25501160, 26021054, 26130635, and 26200964. If your bottle matches any of these numbers, it is part of the recall regardless of whether you have taken a dose yet. Since the remedy is not explicitly detailed in the initial announcement, your best path forward is to rely on the chain of care: doctor first for medical advice, then pharmacy for logistical support and disposal. Do not attempt to sell or give away the medication, as this could inadvertently harm others who are unaware of the stability failure.
Your refund, repair, or replacement options
When a medication like Fluphenazine HCl Elixir is recalled, the immediate question on most people’s minds is often about their wallet and their health insurance. It is completely natural to worry about whether you will be out of pocket for a product that failed to meet safety standards. However, it is important to start with a clear and honest reality check based on the official FDA recall details: the specific remedy—whether that be a full refund, a store credit, or a direct replacement—is not currently stated in the public record for this Safecor Health recall.
This does not mean you are left without recourse. In the pharmaceutical industry, when a Class II recall is issued due to failed stability specifications, the standard expectation is that the manufacturer will work with distributors and healthcare providers to resolve the issue for patients. Because the remedy is not explicitly listed, you should not assume that no action is available. Instead, you must proactively seek out the resolution through the official channels. The goal here is to ensure that you are not financially penalized for a product defect that was beyond your control.
Your first and most critical step is to contact the entity from which you purchased or were prescribed the medication. If you received this elixir directly from a pharmacy, reach out to their pharmacist immediately. Pharmacists are trained to handle recall logistics and often have direct lines to the distributor or manufacturer to process returns and issue credits or refunds. They may also guide you on how to obtain a replacement prescription if your health insurance will cover it, potentially waiving any copay differences due to the recall.
If you are a healthcare provider or a facility managing inventory, you should contact Safecor Health directly at their Woburn, Massachusetts address. While the phone number is not provided in the current facts, the manufacturer is legally obligated to facilitate the return of these specific lots. They will likely provide instructions on how to ship the product back or arrange for pickup, ensuring that you are reimbursed according to standard wholesale distribution agreements.
It is also worth noting that because this recall is due to failed stability specifications rather than contamination or acute toxicity, the primary remedy is likely financial restitution or the provision of a new, stable batch. You should keep all your receipts and documentation of the lot numbers (specifically 26160463, 25430188, 25440715, 25501160, 26021054, 26130635, and 26200964) handy. These details are essential for verifying your claim. Do not throw away the bottle until you have confirmed the return process with the pharmacy or manufacturer, as they may need to verify the physical product before issuing any refund.
If you encounter resistance or confusion from a retailer, escalate the matter to your health insurance provider’s customer service. Explain that you are holding a recalled Class II drug and ask for assistance in obtaining a replacement or reimbursement. Insurance companies often have protocols for recall-related claims that can simplify this process for you. Remember, the burden of proof is on the manufacturer, not you, so remain calm but persistent in your inquiries.
What can happen if you ignore it
When a medication like Fluphenazine HCl Elixir is recalled due to failed stability specifications, the immediate concern might seem abstract—after all, the bottle looks the same and the label hasn’t changed. However, ignoring this recall carries specific, tangible risks that stem directly from the chemical reality of what happens when drugs degrade. Stability failures mean that the active ingredient, in this case fluphenazine hydrochloride, is breaking down or changing concentration at a rate faster than intended. This is not merely a matter of the pill losing its "freshness"; it is a fundamental alteration of the drug’s chemical integrity. For a central nervous system depressant like fluphenazine, which is prescribed to manage conditions such as schizophrenia and other psychotic disorders, precise dosing is critical to patient safety and therapeutic efficacy.
If you continue to use this product without replacing it, you face two primary dangers: under-dosing and unpredictable side effects. Because the drug has failed stability testing, the actual amount of active medication in each 5 mL dose may be lower than what is printed on the label. If you are taking this medication to maintain mental health stability, receiving less than the prescribed dose can lead to a sudden return of symptoms that were previously under control. This is not a gradual drift; for many patients, missing even a small percentage of their required dosage can trigger a relapse, leading to severe emotional distress, behavioral changes, or a crisis that requires emergency intervention. The gap between "feeling okay" and "experiencing a psychotic episode" can be surprisingly narrow when the medication itself is compromised.
Conversely, degradation does not always mean the drug simply becomes weaker. Chemical breakdown can sometimes create unknown byproducts or alter the potency in unpredictable ways. Fluphenazine has a narrow therapeutic index for many users, meaning the difference between a helpful dose and a toxic one is small. If the stability failure results in uneven distribution of the active ingredient within the elixir, you might inadvertently receive a dose that is too high, increasing the risk of serious side effects such as severe drowsiness, muscle stiffness, tremors, or irregular heart rhythms. While the recall facts provided by the FDA do not list specific reported injuries or incidents for this particular batch, the nature of stability failures in psychiatric medications makes adverse outcomes highly probable because the body can no longer rely on a consistent chemical input.
Furthermore, delaying replacement creates a logistical risk that compounds the health danger. If you wait too long, you may run out of medication entirely during a period when your current supply is chemically unreliable. Re-establishing care with a healthcare provider takes time—appointments are often booked weeks in advance. During this gap, you would be left without any treatment for a serious condition, which is far more dangerous than dealing with the inconvenience of a recall. The "ignore it" approach assumes that the consequences are minor, but in psychiatry, continuity of care is the cornerstone of stability. Letting a stability failure slide disrupts that continuity, potentially leading to hospitalization or long-term health setbacks that could have been avoided by simply swapping the bottle.
- Loss of Symptom Control: The most common real-world consequence is the return of untreated psychiatric symptoms due to lower-than-expected drug potency.
- Unpredictable Toxicity: Degraded compounds may cause unexpected side effects, including severe drowsiness or cardiovascular issues.
- Care Gaps: Delaying action can lead to a complete lack of medication while waiting for provider appointments, creating a dangerous void in treatment.
Staying safe: broader tips
While this specific recall involves pharmaceutical stability issues, the broader lesson applies to how we manage medication safety in our daily lives. Fluphenazine HCl is a prescription antipsychotic medication often used to treat conditions like schizophrenia. Because it affects the central nervous system, ensuring its potency and safety is critical. When you are handling any prescription drug, especially those with complex chemical compositions or specific storage requirements, your home environment plays a huge role in maintaining product integrity. Always store medications exactly as directed on the label or by your pharmacist. For elixirs and liquid formulations, which can be sensitive to temperature fluctuations and light exposure, keeping them in a cool, dry place away from direct sunlight is not just a suggestion—it is a key part of preventing degradation before you even open the bottle.
One of the most effective ways to stay safe is to establish a routine for checking your medicine cabinet. Many people assume that if a medication looks and smells normal, it is still good. However, chemical changes can occur without obvious visual cues until it is too late. Set a reminder every few months to review your medications. Check expiration dates carefully, not just the ones on the front of the bottle but also on individual blister packs or vials. If you have any doubts about the integrity of a product, or if you notice unusual sedimentation, cloudiness, or discoloration in liquid medicines, do not take it. Contact your healthcare provider or pharmacist for guidance. It is always better to be cautious than to risk ingesting a compromised product.
Additionally, stay informed about recalls beyond just the ones that make the news. The FDA and other regulatory bodies issue hundreds of recalls each year for various reasons, from labeling errors to potential contamination. You can sign up for email alerts on the FDA’s official website to receive notifications about drug and medical device recalls relevant to your health needs. This proactive approach ensures that you are not caught off guard by safety issues that might affect medications you or your family members use regularly.
Finally, never share prescription medications with others, even if they have similar symptoms. What is safe and effective for one person may be harmful to another due to differences in metabolism, age, weight, or other health conditions. Always consult with a healthcare professional before starting, stopping, or changing the dosage of any prescription drug. By taking these general steps—proper storage, regular checks, staying informed, and seeking professional advice—you can significantly reduce risks associated with medication use and ensure that you are getting the safe, effective treatment you need.